Biotest Has 300 Million Euros for Acquisitions, Boersen Reports
Stock Chart for Biotest AG (BIO)
Targets may include makers of clotting agents, the newspaper cited the CFO as saying.
To contact the reporter on this story: Cornelius Rahn in Frankfurt at email@example.com
To contact the editor responsible for this story: Kenneth Wong at firstname.lastname@example.org
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.